Manufacturing Business News: Eli Lilly to Invest Billions in U.S. Manufacturing, Kung-Fu Robots and Other Headlines

While we have a great staff of dedicated editors here at IndustryWeek, we can’t write about everything. So, here’s a roundup of news from our parent company Endeavor Business Media’s many news brands.

• Eli Lilly to Invest $27B in US Drug Manufacturing Sites as Trump Threatens Pharmaceutical Tariffs: Pharma Manufacturing Editor-in-Chief Greg Slabodkin explores Eli Lilly’s investment to build four new U.S. manufacturing sites. Lilly expects the $27 billion investment to strengthen the company’s supply chain amid reports of upcoming pharmaceutical tariffs. The sites are expected to create over 3,000 skilled jobs and begin making medicines within five years.
• Air Products Cancels Three U.S.-Based Projects: Air Products has terminated an agreement with World Energy for a sustainable aviation fuel-expansion project in California, dropped plans to construct a green liquid hydrogen facility in New York and terminated a carbon monoxide production project in Texas. Learn more about why the company is exiting these projects from Chemical Processing Managing Editor Amanda Joshi.
• Unitree Releases Kung-Fu Robots on the World: Unitree’s G1 humanoid robot “can perform dynamic movements, such as standing up, folding in half, kicking its legs in the air, turning its torso 180 degrees, maintaining balance if pushed, etc.,” writes New Equipment Digest Editor-in-Chief Laura Davis. Click the link above to see the robot in action and learn more about its capabilities.
• The Economic Tug-of-War: How U.S. Tariffs Are Shaping the Healthcare Supply Market: Hear from Rhino Medical Supply's Chief Supply Chain Officer Charles Vartanian in this Q&A style article from Healthcare Purchasing News Editor-in-Chief Janette Wider. Vartanian speaks on the company’s history, common tariff misconceptions and challenges to reshoring in the healthcare industry.